Charite University, Berlin, Germany: Spondylitis, Ankylosing trials
The registry lists 12 Spondylitis, Ankylosing studies with Charite University, Berlin, Germany as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 2 7Phase 3 3Phase 4 2No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- German Spondyloarthritis Inception CohortRecruitingNCT01277419
- NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing SpondylitisCompletedNCT02758782Phase 4
- Ustekinumab for the Treatment of Patients With Active Ankylosing SpondylitisCompletedNCT01330901Phase 2
- Etanercept (Enbrel) in Ankylosing SpondylitisStatus unknownNCT01289743Phase 2
- Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing SpondylitisCompletedNCT00715091Phase 4
- Pilot Open Label Clinical Trial With Abatacept in Ankylosing SpondylitisStatus unknownNCT00558506Phase 2
- Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing SpondylitisStatus unknownNCT00432653Phase 2/3
- Referral Recommendations for Axial SpondyloarthritisCompletedNCT00383617
- Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)Status unknownNCT00328068
- Prednisolone in Active Ankylosing Spondylitis (AS)Status unknownNCT00244166Phase 2/3
- Methotrexate in Ankylosing Spondylitis (MTX in AS)Status unknownNCT00243750Phase 2
- D2E7-Early ASStatus unknownNCT00235105Phase 2/3